Working together to provide support to countries in light of Global Fund new funding model Nigeria Country Experience Dr A. O. Awe, NPO TUB/WHO.

Working together to provide support to countries in light of Global Fund new

funding model

Nigeria Country

Experience

Dr A. O. Awe, NPO TUB/WHO

Outline

1. Country name, submission date

2. Partners involved Lessons learned:

3. What worked well

4. What didn't work well

Nigeria Current TB grant

• Current TB GF Grant: Phase 2 of Rd 9

• Phase 2 period: Jan 2013 –June 2015

• 2 PRs: ARFH IHVN (MDR component)

Country NFM Process• The Nigeria CCM is coordinating the development

and submission of concept notes using the New Funding Model (NFM) to access funding for HIV/AIDS, Tuberculosis, Malaria and Health System Strengthening (HSS).

• The HMH chairs the CCM; WHO WR act as RMC chair

• Key feature of NFM is the “country dialogue”.

• The CCM also coordinated the Roadmap for the Joint TB/HIV Concept Note writing.

Road map for NFM• CCM constituted a Multi-stakeholder NFM Core

Team with clear ToR to drive the preparation and application processes

• Included governments, donors, technical partners, civil society, and key affected and most-at-risk populations.

• The country dialogue led to identification of national strategies, resource available, TA needs and country prioritized activities for TB/HIV .

• Joint TA plan and ToRs developed; recruitment of TAs still on-going (19 thematic areas identified for TA support for the TB/HIV concept note)

Nigeria NFM TB/HIV timelines Key dates: in discussion with GF secretariat;

•CCM Final TB/HIV CN submission: 15 August 2014

•Technical Review Panel (TRP) review: 15 Sept 2014

•1st Grant Approvals Committee (GAC) meeting: Sept 2014

•Grant making: October 2014- January 2015

•2nd GAC meeting: February 2015

•Board meeting/approval: March 2015

•Sign additional grant funding: by April 2015

•Availability of new grant funding: 1 July 20156

Progress with Ingredients for Joint Concept NoteComponent COMPLETION?? Key TA Provision

by ??TB HIV

1 National Program review YES YES WHO, KNCV, USAID, CDC, etc

2 National Strategic Plan Almost YES D arcy/ Daniella3 Epi Analysis YES YES Babis(WHO HQ)4 Programmatic/Financial

Gap AnalysisYes Ongoing

5 Target setting Yes On going

D arcy/ Daniella, UNAIDS

6 HSS assessment /analysis Ongoing “” WHO7 Identify joiTB/HIV priorit Ongoing On No Ext consultant

8 Consultative/technical meetings b/w GF and PEPFAR on Prioritization of support; HELD

GF, USAID, GON

TA SUPPORT REQUEST AREA ACCORDING TO NFM MODULES

TA SUPPORT REQUEST AREA ACCORDING TO NFM MODULES

EXTERNAL TAs INVOLVED

1 TB Care and Prevention USAID, KNCV, WHO

2 MDR TB KNCV, WHO, USAID

3 PMTCT UNICEF

4 ART WHO

5 HIV Prevention and Most Risked person

UNAIDS, UNDP, UNODC

6 Health System Strengthening WHO, UNDP

7 NFM Concept note drafting (narrative sections)

WHO

8 Concept note development leadership

UNAIDS (HIV); USAID/KNCV (TB)HSS (WHO)

9 Cross cutting support UNAIDS, UNDP, WHOMarch 2012Off-Cycle Phase 2 Panel 8

What worked well• Central coordination by CCM

• Harmonisation of roadmap; TA needs.

• Readiness of stakeholders and Partners to dialogue to identify way forward.

• National TB and HIV Programme and stakeholders working closely together on the processes of the joint concept note writing

• Coordination of TA from TBTEAM, WHO, KNCV and UNAIDs

What did not work well/ Challenges

• Not all TA pledged / consultants were available at time specified, especially on HIV side

• Still looking for external TB/HIV consultant

• Shifting dates on roadmap

THANK YOU!